Neogen Corporation Royalty Expense
Neogen Corporation (NEOG) reported Royalty Expense of $1.90 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2026-07-30
- Neogen Corporation royalty expense for fiscal 2026 was $1.90M, a 18.75% increase from fiscal 2025.
- Neogen Corporation royalty expense for fiscal 2025 was $1.60M, a 51.52% decline from fiscal 2024.
- Neogen Corporation royalty expense for fiscal 2024 was $3.30M, a 2.71% decline from fiscal 2023.
- Neogen Corporation royalty expense for fiscal 2023 was $3.39M, a 69.68% increase from fiscal 2022.
| Period end | Royalty Expense | Royalty Expense 12 month | Royalty Expense 12 month as first filed |
|---|---|---|---|
| 2026-05-31 | $1.90M 10-K · filed 2026-07-30 | ||
| 2025-05-31 | $1.60M 10-K · filed 2026-07-30 | $1.60M 10-K · filed 2025-07-30 | |
| 2024-05-31 | $3.30M 10-K · filed 2026-07-30 | $3.25M 10-K · filed 2024-07-30 | |
| 2023-05-31 | $3.39M 10-K · filed 2025-07-30 | ||
| 2022-05-31 | $2.00M 10-K · filed 2024-07-30 | ||
| 2021-09-17 | $14.50M 10-Q · filed 2023-04-04 | ||
| 2021-05-31 | $2.13M 10-K · filed 2023-08-15 | ||
| 2020-05-31 | $2.52M 10-K · filed 2022-07-27 | ||
| 2019-05-31 | $2.79M 10-K · filed 2021-07-30 | ||
| 2018-05-31 | $2.88M 10-K · filed 2020-07-30 | ||
| 2017-05-31 | $2.66M 10-K · filed 2019-07-30 | ||
| 2016-05-31 | $1.97M 10-K · filed 2018-07-27 | ||
| 2015-05-31 | $2.19M 10-K · filed 2017-07-28 | ||
| 2014-05-31 | $2.28M 10-K · filed 2016-07-29 | ||
| 2013-05-31 | $1.84M 10-K · filed 2015-07-30 | ||
| 2012-05-31 | $1.37M 10-K · filed 2014-07-30 | ||
| 2011-05-31 | $1.56M 10-K · filed 2013-07-30 | ||
| 2010-05-31 | $1.34M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |